0000950123-19-007984.txt : 20190814
0000950123-19-007984.hdr.sgml : 20190814
20190814090122
ACCESSION NUMBER: 0000950123-19-007984
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190630
FILED AS OF DATE: 20190814
DATE AS OF CHANGE: 20190814
EFFECTIVENESS DATE: 20190814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bain Capital Life Sciences Investors, LLC
CENTRAL INDEX KEY: 0001703031
IRS NUMBER: 813996001
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18477
FILM NUMBER: 191023108
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6175162878
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001703031
XXXXXXXX
06-30-2019
06-30-2019
Bain Capital Life Sciences Investors, LLC
200 Clarendon Street
Boston
MA
02116
13F HOLDINGS REPORT
028-18477
Y
Bain Capital Life Sciences Investors, LLC is the general partner of Bain Capital Life Sciences Partners, LP, which is the general partner of Bain Capital Life Sciences Fund, L.P.
Adam Koppel
Managing Dir. of Bain Capital Life Sciences Investors, LLC
617-516-2000
/s/ Adam Koppel
Boston
MA
08-14-2019
2
5
196868
false
1
28-18476
Bain Capital Life Sciences Partners, LP
2
28-18478
Bain Capital Life Sciences Fund, LP
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
DICERNA PHARMACEUTICALS INC
COM
253031108
115451
7330237
SH
SOLE
7330237
0
0
MARINUS PHARMACEUTICALS INC
COM
56854Q101
20927
5042735
SH
SOLE
5042735
0
0
REPLIMUNE GROUP INC
COM
76029N106
41619
2838968
SH
SOLE
2838968
0
0
SOLID BIOSCIENCES INC
COM
83422E105
11439
1989444
SH
SOLE
1989444
0
0
APTINYX INC
COM
03836N103
7432
2225092
SH
SOLE
2225092
0
0